What question did this study set out to answer?

This trial aimed to assess the effects of synbiotic yogurt on insulin resistance and atherogenic indices in adults with metabolic syndrome.

July 11, 2026Nutrition & MetabolismOpen Access

The impact of synbiotic yogurt consumption on insulin-resistance surrogates, atherogenic and novel anthropometric indices in adults with metabolic syndrome: a randomized clinical trial

View Full Paper

Ask AI

Bookmark

This trial aimed to assess the effects of synbiotic yogurt on insulin resistance and atherogenic indices in adults with metabolic syndrome.
12-week double-blind, standard-yogurt-controlled randomized clinical trial.
Enrolled 44 adults with metabolic syndrome; 41 completed the study.
Participants received either 300 g/day of synbiotic yogurt or a control yogurt.
Significant improvements were observed in control group indices CRI-I (p = 0.039), CRI-II (p = 0.038), AC (p = 0.039), and BAI (p = 0.027).
The control group showed reductions in AIP, CRI-I, CRI-II, AC, TG/HDL, and METS-IR.
Participants consuming synbiotic yogurt had significant decreases only in TyG and TyG-BMI.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Randomized trial evaluates synbiotic yogurt effects on insulin resistance and cardiometabolic health in adults with metabolic syndrome, indicating limited benefits.

Cite This Study

Jowshan et al. (2026) studied this question.

synapsesocial.com/papers/6a51dce1c18d7f28ca4ffd5a https://doi.org/10.1186/s12986-026-01175-4

View Full Paper

Ask AI

Bookmark

Implication

Randomized trial evaluates synbiotic yogurt effects on insulin resistance and cardiometabolic health in adults with metabolic syndrome, indicating limited benefits.

The impact of synbiotic yogurt consumption on insulin-resistance surrogates, atherogenic and novel anthropometric indices in adults with metabolic syndrome: a randomized clinical trial

Key Points

Discussion

Implication

Cite This Study

The impact of synbiotic yogurt consumption on insulin-resistance surrogates, atherogenic and novel anthropometric indices in adults with metabolic syndrome: a randomized clinical trial

Key Points

Discussion

Implication

Cite This Study